Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cytokinetics
Podcast
'The Top Line': 2023's exclusivity losses, this week's news
This week on "The Top Line," we discuss AbbVie's Humira patent cliff and the other big drugs losing exclusivity in 2023, as well as this week's top news.
Teresa Carey
Apr 7, 2023 7:30am
Cytokinetics' heart failure drug gets a thumbs-down from FDA
Feb 28, 2023 8:25pm
'The Top Line': Medtech's highest paid CEOs, this week's news
Dec 16, 2022 6:00am